|
Re: Compilation of BET inhibitor Trials
|
6
|
Zenith Epigenetics
|
Oct 09, 2017 01:39PM
|
|
Re: The Prescription
|
6
|
Resverlogix Corp.
|
Nov 16, 2017 11:10AM
|
|
Resverlogix poster at American Diabetes Association meeting on Sunday June 7
|
6
|
Resverlogix Corp.
|
Jun 05, 2015 08:23PM
|
|
Re: Tick Bites?
|
6
|
Resverlogix Corp.
|
Jul 30, 2018 10:28PM
|
|
Re: RVX AGM and Zenith AGM, my thoughts
|
6
|
Resverlogix Corp.
|
Sep 12, 2016 06:46PM
|
|
Re: Financials are out
|
6
|
Resverlogix Corp.
|
Jul 30, 2018 10:50PM
|
|
Re: A few upcoming conference appearances
|
6
|
Resverlogix Corp.
|
Apr 02, 2021 04:44PM
|
|
Re: Q4 2019 Events
|
6
|
Resverlogix Corp.
|
Oct 07, 2019 04:14PM
|
|
Re: The journey to the finish line
|
6
|
Resverlogix Corp.
|
May 12, 2018 04:45PM
|
|
Re: RVX AHA Presentation 191116 Transcript - rough
|
6
|
Resverlogix Corp.
|
Nov 16, 2019 08:57PM
|
|
Re: Can we infer perhaps that BETonMACE is properly powered from the FDA news?
|
6
|
Resverlogix Corp.
|
Jun 18, 2018 08:49AM
|
|
Re: Back to the FDA
|
6
|
Resverlogix Corp.
|
Oct 04, 2019 07:19AM
|
|
Re: RESVERLOGIX EXCEEDS FULL ENROLLMENT FOR THE PIVOTAL PHASE 3 BETONMACE CLINICAL TRIAL
|
6
|
Resverlogix Corp.
|
Mar 19, 2018 11:36AM
|
|
Re: What Monday Brings?
|
6
|
Zenith Epigenetics
|
Jun 16, 2016 11:26PM
|
|
Re: Upcoming CVOT results
|
6
|
Resverlogix Corp.
|
Apr 15, 2019 08:14AM
|
|
Re: AGM 2018 - Masila Notes
|
6
|
Resverlogix Corp.
|
Jun 13, 2019 08:59AM
|
|
The importance of sub-group analyses
|
6
|
Resverlogix Corp.
|
Dec 18, 2018 05:18PM
|
|
Re: How to best promote apabetalone?
|
6
|
Resverlogix Corp.
|
Oct 30, 2017 10:06PM
|
|
Re: A competitor?
|
6
|
Resverlogix Corp.
|
Nov 03, 2017 12:19PM
|
|
Re: anyone thinking halt for NR before presentation tomorrow?
|
6
|
Resverlogix Corp.
|
Oct 12, 2016 04:06PM
|
